Sara T. Wester

Teprotumumab for the Treatment of Active Thyroid Eye Disease

Raymond S. Douglas, George J. Kahaly, Amy Patel et al. · New England Journal of Medicine · 2020 · 700 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +11

Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment

Raymond S. Douglas, George J. Kahaly, Shoaib Ugradar et al. · Ophthalmology · 2021 · 158 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +13

Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity

Raymond S. Douglas, Steven M. Couch, Sara T. Wester et al. · The Journal of Clinical Endocrinology & Metabolism · 2023 · 69 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +10

Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival

Robert Gerring, C T Ott, Joseph Curry et al. · Eye · 2016 · 63 citations · Full text

Medicine, Oncology, Surgery +16

Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease

George J. Kahaly, Peter J. Dolman, Jan Wolf et al. · The Journal of Clinical Endocrinology & Metabolism · 2023 · 61 citations · Full text

Medicine, Endocrinology, Pharmacology +15